Article
ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.
Journal of diabetes research - 1 Jan 2014
Ha Sung-Kyu
Abstract excerpt
Approximately 20-40% of diabetic patients develop nephropathy which is the leading cause of ESRD in developed countries. The ACE I/D polymorphism is thought to be a marker for functional polymorphism which regulates circulating and tissue ACE activity. While the initial study found a protective effect of the II genotype on the development of nephropathy in IDDM patients, subsequent studies have addressed the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
